Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

SecurityAGIO / Agios Pharmaceuticals, Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership399 shares
Latest Disclosed Value $ 13,498
Signaturefd, Llc ownership in AGIO / Agios Pharmaceuticals, Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 399 shares of Agios Pharmaceuticals, Inc. (US:AGIO) valued at $13,498 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 399 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $11,288 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 399 0 0.00 13 30.00 0.0002
2026-01-20 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 399 -114 -22.22 11 -50.00 0.0002
2025-10-21 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 513 0 0.00 21 17.65 0.0003
2025-07-16 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 513 36 7.55 17 30.77 0.0003
2025-05-02 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 477 -34 -6.65 14 -18.75 0.0003
2025-02-10 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 511 11 2.20 17 -27.27 0.0003
2024-10-21 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 500 12 2.46 22 4.76 0.0004
2024-07-29 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 488 -5 -1.01 21 50.00 0.0004
2024-05-03 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 493 -200 -28.86 14 -6.67 0.0003
2024-02-01 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 693 22 3.28 15 -6.25 0.0004
2023-11-03 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 671 -68 -9.20 17 -20.00 0.0004
2023-08-01 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 739 -28 -3.65 21 17.65 0.0005
2023-04-28 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 767 -214 -21.81 18 -37.04 0.0005
2023-01-30 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 981 -22 -2.19 28 -3.57 0.0008
2022-11-08 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,003 482 92.51 28 133.33 0.0010
2022-08-10 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 521 402 337.82 12 300.00 0.0004
2022-05-02 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 119 74 164.44 3 200.00 0.0001
2022-01-25 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 45 -28 -38.36 1 -66.67 0.0000
2021-10-28 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 73 -105 -58.99 3 -70.00 0.0001
2021-07-26 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 178 68 61.82 10 66.67 0.0004
2021-04-30 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 110 37 50.68 6 100.00 0.0003
2021-02-11 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 73 0 0.00 3 0.00 0.0001
2020-11-03 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 73 35 92.11 3 50.00 0.0002
2020-07-30 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 38 2 5.56 2 100.00 0.0001
2020-04-23 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 36 -18 -33.33 1 -66.67 0.0001
2020-02-05 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 54 36 200.00 3 200.00 0.0002
2019-10-16 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 18 -31 -63.27 1 -50.00 0.0001
2019-07-31 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 49 21 75.00 2 0.00 0.0002
2019-05-09 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 28 28 2 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.